Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
PG&E
PCG
$38.4B
| $6.79M | ﹤0.01% |
559,100
+131,600
| +31% | +$1.54M |
|
1502
Triumph Financial Inc
TFIN
$1.91B
| $6.79M | ﹤0.01% |
56,988
+19,256
| +51% | +$2.31M |
|
1503
Agree Realty
ADC
$9.49B
| $6.78M | ﹤0.01% |
95,007
-2,744
| -3% | -$190K |
|
1504
Neogen
NEOG
$2.58B
| $6.78M | ﹤0.01% |
149,202
+39,826
| +36% | +$1.7M |
|
1505
JetBlue
JBLU
$2.42B
| $6.76M | ﹤0.01% |
474,618
-222,583
| -32% | -$3.27M |
|
1506
Houlihan Lokey
HLI
$8.96B
| $6.75M | ﹤0.01% |
65,211
+38,781
| +147% | +$4.14M |
|
1507
Floor & Decor
FND
$6.46B
| $6.75M | ﹤0.01% |
51,898
-44,112
| -46% | -$5.68M |
|
1508
CALL
Vipshop
VIPS
$7.49B
| $6.73M | ﹤0.01% |
801,300
| – | – |
|
1509
CALL
Okta
OKTA
$25.7B
| $6.72M | ﹤0.01% |
30,000
+16,300
| +119% | +$3.88M |
|
1510
Nice
NICE
$6.05B
| $6.7M | ﹤0.01% |
22,083
+8,555
| +63% | +$2.47M |
|
1511
Qualys
QLYS
$5.67B
| $6.67M | ﹤0.01% |
48,591
+10,294
| +27% | +$1.32M |
|
|
FMBI
1512
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $6.64M | ﹤0.01% |
324,188
-8,964
| -3% | -$180K |
|
1513
Sabra Healthcare REIT
SBRA
$5.21B
| $6.63M | ﹤0.01% |
489,934
+53,913
| +12% | +$763K |
|
1514
Ryman Hospitality Properties
RHP
$8.09B
| $6.61M | ﹤0.01% |
71,875
+36,973
| +106% | +$3.17M |
|
1515
Rithm Capital
RITM
$5.72B
| $6.6M | ﹤0.01% |
616,157
-193,176
| -24% | -$2.15M |
|
1516
Viavi Solutions
VIAV
$9.95B
| $6.6M | ﹤0.01% |
374,611
-185,705
| -33% | -$2.94M |
|
1517
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $6.59M | ﹤0.01% |
200,000
-161,217
| -45% | -$5.32M |
|
1518
PUT
Nike
NKE
$61.6B
| $6.58M | ﹤0.01% |
39,500
+25,500
| +182% | +$4.21M |
|
1519
CALL
Southwest Airlines
LUV
$23.8B
| $6.58M | ﹤0.01% |
153,500
+53,500
| +54% | +$2.51M |
|
|
LAC
1520
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $6.58M | ﹤0.01% |
225,788
+115,284
| +104% | +$3.45M |
|
|
HPP
1521
Hudson Pacific Properties
HPP
$758M
| $6.55M | ﹤0.01% |
37,870
+3,323
| +10% | +$605K |
|
1522
Steven Madden
SHOO
$3.58B
| $6.55M | ﹤0.01% |
140,920
+24,958
| +22% | +$1.15M |
|
1523
HEICO Corp
HEI
$51.4B
| $6.53M | ﹤0.01% |
45,306
+8,072
| +22% | +$1.14M |
|
1524
CALL
Medpace
MEDP
$16.1B
| $6.53M | ﹤0.01% |
30,000
-21,400
| -42% | -$4.48M |
|
1525
Pacific Biosciences
PACB
$447M
| $6.52M | ﹤0.01% |
318,810
+206,485
| +184% | +$4.98M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.